Untargeted metabolomics analysis reveals the potential mechanism of imatinib-induced skin rash in patients with gastrointestinal stromal tumor
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112728 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Xiao Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Hubei Province Cl…. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Imatinib Mesylate, Metabolomics, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Chinese Pharmaceutical Association.
Abstract (Originalsprache)
Imatinib-induced skin rash poses a significant challenge for patients with gastrointestinal stromal tumor, often resulting in treatment interruption or discontinuation and subsequent treatment failure. However, the underlying mechanism of imatinib-induced skin rashes in gastrointestinal stromal tumor patients remains unclear. A total of 51 patients (27 with rash and 24 without rash) were enrolled in our study. Blood samples were collected concomitantly with the onset of clinical manifestations of rashes, and simultaneously collecting clinical relevant information. The imatinib concentration and untargeted metabolomics were performed by ultra-high-performance liquid chromatography-tandem mass spectrometry. There were no significant differences in age, gender, imatinib concentration and white blood cells count between the rash group and the control group. However, the rash group exhibited a higher eosinophil count (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wu…
- Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Department of Pharmacy, Chongqing Medical University, Chongqing 400016, China.
- Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Department of Gastrointestinal Surgery, Department of Nursing, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Electronic address: zhangpengwh@hust.edu.cn.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Chinese Pharmaceutical Association
Zitieren
APA
Huang, X., Chen, L., Liu, L., Chen, H., Gong, Z., Lyu, J., Li, Y., Jiang, Q., Zeng, X., Zhang, P., & Zhou, H. (2024). Untargeted metabolomics analysis reveals the potential mechanism of imatinib-induced skin rash in patients with gastrointestinal stromal tumor. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112728
Vancouver
Huang X, Chen L, Liu L, Chen H, Gong Z, Lyu J, et al. Untargeted metabolomics analysis reveals the potential mechanism of imatinib-induced skin rash in patients with gastrointestinal stromal tumor. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112728
BibTeX
@article{Huang2024,
author = {Huang, Xiao and Chen, Linhua and Liu, Li and Chen, Hefen and Gong, Zhujun and Lyu, Jianbo and Li, Yao and Jiang, Qi and Zeng, Xiangyu and Zhang, Peng and Zhou, Hong},
title = {Untargeted metabolomics analysis reveals the potential mechanism of imatinib-induced skin rash in patients with gastrointestinal stromal tumor},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112728}
}
EUVIMED